Modulators of TNF receptor associated factor (TRAF), their...

Details Modulators of TNF receptor associated factor (TRAF), their... Modulators of TNF receptor associated factor (TRAF), their...

1997-04-01

2009-02-03

Epps-Ford, Janet L (Department: 1633)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

C435S006120, C435S069100, C435S320100, C424S130100, C530S350000, C536S023100, C536S023500

Reexamination Certificate

active

07485456

ABSTRACT:
A DNA sequence encoding a protein capable of binding to a tumor necrosis factor receptor-associated factor (TRAF) molecule, TRAF-binding proteins, their isoforms, analogs, fragments and derivatives encoded by the DNA sequence, their methods for the production of the DNA sequences and proteins, and the uses for the DNA sequence and proteins.

REFERENCES:
patent: 5641876 (1997-06-01), McElroy et al.
patent: 5804412 (1998-09-01), Gill et al.
patent: 5843721 (1998-12-01), Rothe et al.
patent: 5844073 (1998-12-01), Rothe et al.
patent: 9706182 (1997-02-01), None
Andrea D. Branch, A good antisense molecule is hard to find, TIBS, 47-48, Feb. 1998.
Stanley Crooke, Antisense Research and Applications, Chapter 1, Basic Principles of Antisense Therapeutics, Springer-Verlag Press, Berlin, Heidelberg, New York, p. 3, Jul. 1998.
W. French Anderson, Human gene therapy, Nature, vol. 392, pp. 25-30, Apr. 1998.
Stuart Orkin & Arno Motulsky, Report and Recommendations of the panel to assess the NIH investment in research on gene therapy. NIH web page (http://www.nih.gov), pp. 1-23, Feb. 1995.
W. French Anderson, Human gene therapy, Nature, vol. 392, pp. 25-30, Apr. 1998.
Stuart Orkin & Arno Motulsky, Report and Recommendations of the panel to assess the NIH investment in research on gene therapy. NIH web page (http://www.nih.gov), pp. 1-23, Feb. 1995.
Marshall et al. Gene Therapy's Growing Pains (Science, vol. 269, pp. 1050-1055, Aug. 1995), May 1995.
J Skolnick et al., TIBTECH, “From genes to protein structure and function:novel applications of computational approaches in the genomic era,” Jan. 2000, vol. 18, pp. 34-39.
P Bork, Genome Research, “Powers and Pitfalls in Sequence Analysis:The 70% Hurdle,” 2000, pp. 398-400.
T Doerks et al., TIG,Genetwork,“Protein annotation:detective work for function prediction,” Jun. 1998, vol. 14, No. 6, pp. 248-250.
Branch, A. A good antisense is hard to find. TIBS, Feb. 1998, pp. 45-50.
Mosialos et al., “The Epstein-Barr Virus Transforming Protein LMP1 Engaging Signaling Proteins for the Tumor Necrosis Factors Receptor Family”,Cell, 80:389-399, (1995).
Cheng et al., “TANK, aco-inducer with TRAF2 of TNF- and CD40L-mediated NF-KB activation”, (1995).
Vandenabeele et al., “Two tumour necrosis factor receptor: structure and function”,Trends in Cell Biology, 5:392-399, (1995).
Malinin et al., “MAP3K-related kinase involved in NF-kB induction by TNF, CD95 and IL-1”,Nature, 385:540-544 (1997).
Rothe et al., “The THFR2-TRAF Signaling Complex Contains Two Novel Proteins Related to Baculoviral Inhibitor of Apoptosis Proteins”,Cell, 83:1243-1252, (1995).
Lee et al, “T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors,” J Exp Med 183(2):669-674 (1996).

Affiliated with

Also associated with

Rating

Modulators of TNF receptor associated factor (TRAF), their... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulators of TNF receptor associated factor (TRAF), their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of TNF receptor associated factor (TRAF), their... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4071832